Screener
Immunome IMNM Cash Flow Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| -$73.13M-68.5% | -$53.84M-29.3% | -$69.9M+12.9% | -$57.46M-22.0% | -$43.4M-20.1% | ||
| $957K+50.2% | $603K-1.3% | $629K+39.8% | $589K+43.3% | $637K+16.0% | ||
| $8.8M+64.6% | $7.95M+39.5% | $7.89M+44.3% | $6.75M+37.9% | $5.35M+65.7% | ||
| -$61.69M-24.9% | -$58.64M-10.5% | -$47.95M-14.0% | -$40.51M-18.6% | -$49.4M-111% | ||
| $2.18M+140% | $3M-18.1% | $4M+255% | $1.12M-27.5% | $905K-61.4% | ||
| —— | —— | —— | —— | —— | ||
| -$304.35M-374% | -$12.02M-336% | $0— | $123.88M— | -$64.17M+21.4% | ||
| $1.06M— | -$135K-100% | $432.8M+2,055% | $45.39M+14,782% | $0-100% | ||
| -$364.99M— | -$70.79M-162% | $380.84M— | $128.76M— | —— | ||
| -$63.87M-27.0% | -$61.64M-8.7% | -$51.95M-20.3% | -$41.63M-16.6% | -$50.31M-95.4% |
FAQ
- How much cash does Immunome generate?
- Immunome (IMNM) generated -$208.8M in operating cash flow over the trailing twelve months.
- What is Immunome's free cash flow?
- After $10.3M of capital expenditures, Immunome's free cash flow was -$219.1M over the trailing twelve months, down 17.8% year over year.
- Where does Immunome's cash flow data come from?
- Every line is extracted from Immunome's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.